UOTTAIMCU
JAZZ icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Jazz Pharmaceuticals JAZZ Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-264
Closed -$32.5K – 183
2023
Q4 		$32.5K Hold
264
– – 0.01% 132
2023
Q3 		$34.2K Buy
+264
New +$35.2K 0.01% 67

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s JAZZ Position: Q1 2024 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 264 shares — an estimated $32.5K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in JAZZ in Q3 2023 and held it in 2 quarters. The position peaked at $34.2K in Q3 2023. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 264 Jazz Pharmaceuticals shares in Q1 2024, an estimated $32.5K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Jazz Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Jazz Pharmaceuticals position peaked at $34.2K in Q3 2023.
  • 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2024, filed 30 Apr 2024.